Adjusting Your eCOA Strategy For Patient Centricity: Expert Advice - a podcast by Pharma Talk Radio

from 2022-09-26T04:00

:: ::

About The Episode

As patient-centricity influences every part of the clinical trial process, sponsors may be surprised at how they impact eCOA strategy. 

On this episode, THREAD Research's Chris Watson and Rebecca Tomalty share their expertise and experience, strategizing and developing patient-centric eCOAs to avoid surprise costs and delays. Listeners will learn: when to start thinking about eCOA implementation, the unexpected hurdles that can pop up, the ways that patient-centricity has impacted future eCOA planning, and the questions to be asking of your eCOA partners. 


About the Speakers: 

Chris Watson, Director, Consulting, THREAD

Chris has over 27 years of experience in product and service development within regulated industries across multiple markets. The last 13+ years have focused on Clinical technologies, including tools and platforms to engage, educate and retain participants (and their families) in clinical studies. Chris is a recognised subject matter expert in eCOA and patient engagement, with a proven ability in the technical domain. 

 

Rebecca Tomalty, Director of eCOA and Translations, THREAD

Rebecca has 20 years of industry experience, primarily in Operations. After several years of experience as a Project Manager, she moved to Clinical Outcome Assessment management in the form of scale management (eCOA Licensing and copyright management and Translations) and, most recently, eCOA design and oversight. As Director of eCOA and Translation Services, she has operational oversight for these two key areas of engagement.

 

For more information on disruptive innovations in clinical research, click here.

Further episodes of PharmaTalkRadio

Further podcasts by Pharma Talk Radio

Website of Pharma Talk Radio